During the past decade, Yonsei University College of Medicine conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 4 clinical trials were completed, i.e. on average, 4.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 2 clinical trials were completed. i.e. 7.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yonsei University College of Medicine" #1 sponsor was "Yonsei University" with 108 trials, followed by "Severance Hospital" with 6 trials sponsored, "National Cancer Center, Korea" with 4 trials sponsored, "Corestem, Inc." with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yonsei University College of Medicine" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Samsung Medical Center" with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator, "Changhua Christian Hospital" with 1 trials as a collaborator and "Chonbuk National University" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Yonsei University College of Medicine" are "Coronary Artery Disease" (9 trials), "Gastric Cancer" (5 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (3 trials) and "Chronic Hepatitis B" (3 trials). Many other conditions were trialed in "Yonsei University College of Medicine" in a lesser frequency.

Most popular intervention types in "Yonsei University College of Medicine" are "Drug" (55 trials), "Procedure" (24 trials), "Device" (17 trials), "Other" (15 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Metformin" (2 trials), "Pioglitazone" (2 trials) and "Rosuvastatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yonsei University College of Medicine" are 127 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 34 active trials in "Yonsei University College of Medicine". 5 are not yet recruiting, 22 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 62 completed trials in Yonsei University College of Medicine, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Yonsei University College of Medicine, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 51 trials that are defined as “Not Applicable".